NDC Package 55566-1010-1 Fyremadel

Ganirelix Acetate Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55566-1010-1
Package Description:
1 BLISTER PACK in 1 CARTON / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE
Product Code:
Proprietary Name:
Fyremadel
Non-Proprietary Name:
Ganirelix Acetate
Substance Name:
Ganirelix Acetate
Usage Information:
Ganirelix acetate injection is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.
11-Digit NDC Billing Format:
55566101001
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2587594 - Fyremadel 250 MCG in 0.5 ML Prefilled Syringe
  • RxCUI: 2587594 - 0.5 ML ganirelix acetate 0.5 MG/ML Prefilled Syringe [Fyremadel]
  • RxCUI: 2587594 - 0.5 ML Fyremadel 0.5 MG/ML Prefilled Syringe
  • RxCUI: 2587594 - Fyremadel 250 MCG per 0.5 ML Prefilled Syringe
  • RxCUI: 855200 - ganirelix acetate 250 MCG in 0.5 ML Prefilled Syringe
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ferring Pharmaceuticals Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA204246
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    02-28-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55566-1010-1?

    The NDC Packaged Code 55566-1010-1 is assigned to a package of 1 blister pack in 1 carton / 1 syringe in 1 blister pack / .5 ml in 1 syringe of Fyremadel, a human prescription drug labeled by Ferring Pharmaceuticals Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

    Is NDC 55566-1010 included in the NDC Directory?

    Yes, Fyremadel with product code 55566-1010 is active and included in the NDC Directory. The product was first marketed by Ferring Pharmaceuticals Inc. on February 28, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 55566-1010-1?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 55566-1010-1?

    The 11-digit format is 55566101001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-155566-1010-15-4-255566-1010-01